John P. Quinn
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
Journal: European journal of haematology
Published: June 30, 2026
Junctional Adhesion Molecule-A (JAM-A) Associates With High-Risk Disease in Multiple Myeloma Patients and a Structure-Based Rationally-Designed Peptide Inhibitor Attenuates Tumorigenic Features In Vitro and In Vivo.
Journal: European journal of haematology
Published: March 24, 2026
Fibrin-associated large B-cell lymphoma presenting in a renal transplant patient.
Journal: British journal of haematology
Published: March 10, 2026
Establishment of a reference interval for calculated globulin on the Roche platform.
Journal: Annals of clinical biochemistry
Published: July 29, 2025
Anaplastic Large Cell Lymphoma Related to Breast Implant Presenting as a Solid mass: A Case Report.
Journal: Case reports in surgery
Published: March 07, 2025
Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on "Targeted anti-cancer agents and risk of venous thromboembolism".
Journal: Haematologica
Published: January 23, 2025
Neonatal Outcomes following 2 Cases of Maternal CAR-T Therapy for High-Grade B-Cell Lymphoma.
Journal: Neonatology
Published: July 29, 2024
Dermal mass with an annular figurate pattern in a patient with leukaemia.
Journal: Clinical and experimental dermatology
Published: June 30, 2024
Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.
Journal: Irish journal of medical science
Published: March 22, 2024
Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants.
Journal: British journal of haematology
Published: August 03, 2023
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.
Journal: Haematologica
Published: June 29, 2023
Genetic Abnormalities in Extramedullary Multiple Myeloma.
Journal: International journal of molecular sciences
Published: June 06, 2023
Last Updated: 09/26/2026